Come up with a name for your new list and we'll add to it:
Bone Biologics raised a round of funding on March 15, 2010. Investors include
Musculoskeletal Transplant Foundation.
Bone Biologics (OTCQB:BBLG) was founded to pursue regenerative medicine for bone. The company is building on research on the Nell-1 molecule that has produced a significant number of studies and publi…